PRECIGEN, INC. Operating Leases, Future Minimum Payments, Due in Three Years
PRECIGEN, INC. (PGEN) had Operating Leases, Future Minimum Payments, Due in Three Years of $7.25 million as of 2018-12-31, per its 10-K filed 2020-03-02.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2020-03-02
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $7.25M; Operating Leases, Future Minimum Payments, Due in Three Years as first filed $9.13M.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $9.58M.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Three Years $9.58M.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Three Years $9.51M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years | Operating Leases, Future Minimum Payments, Due in Three Years as first filed |
|---|---|---|
| 2018-12-31 | $7.25M 10-K · filed 2020-03-02 | $9.13M 10-K · filed 2019-03-01 |
| 2018-09-30 | $9.58M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $9.58M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $9.51M 10-Q/A · filed 2018-08-13 | |
| 2017-12-31 | $9.19M 10-K · filed 2018-03-01 | |
| 2017-09-30 | $8.04M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $7.90M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $6.23M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $5.51M 10-K · filed 2017-03-01 | |
| 2016-09-30 | $5.70M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $2.83M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $2.31M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $2.32M 10-K · filed 2016-02-29 | |
| 2015-09-30 | $2.07M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $1.36M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $1.36M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $2.69M 10-K · filed 2015-03-02 | |
| 2014-09-30 | $2.69M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $2.61M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $2.61M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $2.69M 10-K · filed 2014-03-31 | |
| 2013-09-30 | $2.96M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $2.49M 10-Q/A · filed 2013-10-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |